NewCo Creation
New Company Creation
Our Co-founder Model
What We Look For
Assets: Clinical-stage programs preferably with patient data and validated mechanisms that address unmet medical needs with differentiated best-in-class or first-in-class potential.
Platforms: Transformative, next-generation science that goes beyond incremental innovation in any therapeutic area or modality. For now, cell and gene therapies are deprioritized.
Partnering with Existing Companies
For early-stage biotechs that have completed a seed round, we offer flexible engagement models combining cash and equity, bringing co-founder-level thinking and strategic expertise to accelerate growth. For companies with promising clinical-stage assets ready for dedicated development, Banyan offers a structured path, forming an independent NewCo around the asset, capitalizing it through broad syndication, and deploying a centralized development team to advance it efficiently through key value inflection points.
AN INVESTMENT PLATFORM FOUNDED BY LOCUST WALK
Banyan BioInnovations
AN INVESTMENT PLATFORM FOUNDED BY LOCUST WALK
all win together.